The next-generation system provides intravascular ultrasound (IVUS) and fractional flow reserve (FFR). It uses advanced software and hardware to provide high-quality IVUS vessel imaging and physiology experience. The system’s uses include percutaneous coronary intervention (PCI) procedures.
Boston Scientific’s PCI business continues to grow, particularly in China. The company touched on that and much more at its Investor Day last week — read more here.
Building upon the company’s Avvigo guidance system II, the technology helps to inform treatment decisions. It enables faster, more efficient procedures, such as angioplasties and atherectomies for patients with coronary artery disea…